# Sebastian M. Schellong, M.D., Dresden, Germany – FDA Inspections

Source: https://www.keypedia.com/companies/sebastian-m-schellong-md/6df70369-53d8-4d0c-97c2-e6e90426a7ed

> Inspection records and compliance data for Sebastian M. Schellong, M.D. in Dresden. 1 FDA inspection on record, last inspected May 07, 2014.

---

## Details

- Name: Sebastian M. Schellong, M.D.
- FEI Number: 3010718646
- Address Line 1: Dresden, Friedrichstr. 41
- City: Dresden
- Country Name: Germany
- Address: Dresden, Friedrichstr. 41, Dresden, Germany
- Country: Germany

## Related Documents

- FDA Inspection 878931 - Sebastian M. Schellong, M.D. - 2014-05-07 — classification: No Action Indicated (NAI), source: FDA, date: May 7, 2014

## Related Companies

- [Zentrum Fuer Klinische Studien](https://www.keypedia.com/companies/zentrum-fuer-klinische-studien/10ba6503-c7bb-45b4-ad35-a8abcc01403f)
- [EirGenix GmbH](https://www.keypedia.com/companies/eirgenix-gmbh/cd154afb-0886-4098-beb9-6bcb9222b4b8)
- [Michael D. Staehler](https://www.keypedia.com/companies/michael-d-staehler/ed777dee-aeaf-48d4-bf71-7e69312a635e)
- [Synlab Clinical Trial GmbH Berlin](https://www.keypedia.com/companies/synlab-clinical-trial-gmbh-berlin/9d84733e-8079-4138-bf0f-5652eac395fe)
- [GP Grenzach Produktions GmbH](https://www.keypedia.com/companies/gp-grenzach-produktions-gmbh/6208f27d-ce66-4eb2-8ae0-56bf79a6d8d4)
- [Klinische Forschung](https://www.keypedia.com/companies/klinische-forschung/be83728c-68bd-4a08-9639-589ef732deea)
- [Colep Laupheim Gmbh & Co.](https://www.keypedia.com/companies/colep-laupheim-gmbh-co/53160d0c-4d30-4e2b-8373-e733aa09876a)
- [Bettina Bergtholdt](https://www.keypedia.com/companies/bettina-bergtholdt/bc768d20-0051-4a08-99d3-949dba444091)
- [BioAgilytix](https://www.keypedia.com/companies/bioagilytix/a4342985-488a-46f4-b266-3d3203abab62)
- [Katja Christina Weisel, MD](https://www.keypedia.com/companies/katja-christina-weisel-md/908f1e66-c7f4-486c-9d83-45a645bea961)